SEI Investments’s BioAge Labs BIOA Stock Holding History

SEI Investments’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-62,385	Closed	-$1.09M	–	3419
2026 Q1	$1.09M	Buy	+62,385	New	+$1.2M	﹤0.01%	2315

Other funds holding BIOA

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Jupiter Topco New York $245B AUM

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

SEI Investments's BIOA Position: Q2 2026 in Review

SEI Investments sold out of BioAge Labs (BIOA) in Q2 2026, closing a stake of 62,385 shares — an estimated $1.09M sold.

SEI Investments first reported a position in BIOA in Q1 2026 and held it in 1 quarter. The position peaked at $1.09M in Q1 2026. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

SEI Investments reported no remaining BioAge Labs position as of Q2 2026 after selling out during the quarter.
SEI Investments sold 62,385 BioAge Labs shares in Q2 2026, an estimated $1.09M.
SEI Investments first reported a position in BioAge Labs in Q1 2026 and held it in 1 quarter.
SEI Investments's BioAge Labs position peaked at $1.09M in Q1 2026.
151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.